A new paper from the McArthur & Sheppard Laboratory, by Emily Lelliott et. al.
Scientific Publications
Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ12,14 prostamide J2
Metastatic melanoma is the most deadly skin neoplasm in the United States.
Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis
OBJECTIVES: To compare the incidence of treatment-related necrosis between combination SRS+ICI therapy and SRS therapy alone in patients with brain metastases from melanoma and non-small cell lung cancer (NSCLC).
Comparison of mortality and medical complications between older and younger malignant melanoma inpatients
Because older age has been reported as a negative prognostic factor in malignant melanoma patients in the previous studies, therefore, researchers compared younger and older malignant melanoma inpatients, in terms of comorbidities, medical complications, and inpatient mortality.